Data Insights
Showing 3 results out of 3
Data Insights
Q4 2023 update: immuno-oncology related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that immuno-oncology accounted for 14 pharmaceutical deals announced in Q4 2023,...
Data Insights
Q3 2023 update: immuno-oncology related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that immuno-oncology accounted for 3 pharmaceutical deals announced in...
Data Insights
Innovation in oncology: Leading companies in gene therapy for cancers
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...